Laurion Capital Management LP Novo Cure LTD Call Options Transaction History
Laurion Capital Management LP
- $5.23 Billion
- Q4 2024
Call Options
2 transactions
Others Institutions Holding NVCR
# of Institutions
288Shares Held
76.1MCall Options Held
1.79MPut Options Held
537K-
Black Rock Inc. New York, NY12.1MShares$225 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$209 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$166 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$96.9 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$50.9 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.95B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...